BioNTech, together with Pfizer, has begun work on adapting a
coronavirus vaccine to the omicron strain. The
head of Moderna, in turn, said BioNTech and Pfizer have begun working together to adapt their coronavirus vaccine in case
it doesn't work against the new omicron strain. About it writes
Reuters with reference to the statement of BioNTech. The document states that the development of an adapte...